Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts review of cancer medicine Rubraca 22 Aprile 2022 News Human Referrals Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 April 2022 19 Aprile 2022 News Veterinary Medicines EMA and the EUnetHTA 21 consortium set priorities for their collaboration 12 Aprile 2022 News Human Corporate EMA business hours over Easter holiday 12 Aprile 2022 News Human Corporate COVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022 8 Aprile 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines 6 Aprile 2022 News Human COVID-19 Vaccines Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 Aprile 2022 News Corporate Fees EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice 31 Marzo 2022 News Human Advice to sponsors on managing the impact of the war in Ukraine on clinical trials 30 Marzo 2022 News Human Corporate Clinical trials EU recommendations for 2022-2023 seasonal flu vaccine composition 29 Marzo 2022 News Human Vaccines 1 … 42 43 44 45 46 Page 46 of 379 47 48 49 50 … 379
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 April 2022 19 Aprile 2022 News Veterinary Medicines
EMA and the EUnetHTA 21 consortium set priorities for their collaboration 12 Aprile 2022 News Human Corporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022 8 Aprile 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines
ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines 6 Aprile 2022 News Human COVID-19 Vaccines
Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 Aprile 2022 News Corporate Fees
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice 31 Marzo 2022 News Human
Advice to sponsors on managing the impact of the war in Ukraine on clinical trials 30 Marzo 2022 News Human Corporate Clinical trials